An underwritten public offering of common stock was launched by Thermo Fisher Scientific in hopes of raising $1.5 billion. The company, which intends to grant a 30-day option for the underwriters to purchase up to $225 million in additional shares, said the proceeds will be used for partial funding of its $7.2 billion purchase of contract development and manufacturing organization Patheon.
Public offering could pull in $1.5B for Thermo Fisher Scientific
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.